These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3429442)

  • 1. Antibody to platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF).
    Karasawa K; Fujita K; Satoh N; Hongo T; Setaka M; Ohno M; Nojima S
    J Biochem; 1987 Sep; 102(3):451-3. PubMed ID: 3429442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
    Nishihira J; Ishibashi T; Imai Y
    J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
    Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
    J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies elicited by the bovine lungworm, Dictyocaulus viviparus, cross-react with platelet-activating factor.
    Kooyman FN; de Vries E; Ploeger HW; van Putten JP
    Infect Immun; 2007 Sep; 75(9):4456-62. PubMed ID: 17606606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1122-5. PubMed ID: 1819697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of anti-platelet-activating factor antibodies by the use of colloidal gold as carrier.
    Tomii A; Masugi F
    Jpn J Med Sci Biol; 1991 Apr; 44(2):75-80. PubMed ID: 1956128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining site specificities of rabbit antibodies to platelet-activating factor (PAF).
    Cooney SJ; Smal MA; Harle DG; Baldo BA
    Mol Immunol; 1990 May; 27(5):405-12. PubMed ID: 2366757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity of the binding of platelet activating factor (PAF) to anti-PAF antibodies.
    Smal MA; Baldo BA; Harle DG
    J Mol Recognit; 1990 Aug; 3(4):169-73. PubMed ID: 1703770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-platelet activating factor antibody and its effects on platelet aggregation.
    Tatsumi N; Terano Y; Hashimoto K; Hiyoshi M; Matsuura S
    Osaka City Med J; 1993 Nov; 39(2):167-74. PubMed ID: 8183536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion.
    Frostegård J; Wramsby ML; Wu R; Bremme K
    Am J Obstet Gynecol; 2003 Aug; 189(2):568-73. PubMed ID: 14520236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
    Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
    Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-O-(15-carboxypentadecyl)-2-O-acetyl-sn-glycero-3-phosphorylcholine as a potential platelet activating factor (PAF) hapten.
    Prashad M; Tomesch JC; Wareing JR
    Chem Phys Lipids; 1990 Mar; 53(1):121-6. PubMed ID: 2354543
    [No Abstract]   [Full Text] [Related]  

  • 15. High performance liquid chromatography of platelet-activating factors.
    Jackson EM; Mott GE; Hoppens C; McManus LM; Weintraub ST; Ludwig JC; Pinckard RN
    J Lipid Res; 1984 Jul; 25(7):753-7. PubMed ID: 6481248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG; Tsoukatos DC
    FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of N-(aminobenzoyloxy) succinimide as a two-level heterobifunctional agent for the preparation of hapten-protein conjugates. Daunomycin as a model hapten with an amino group.
    Fujiwara K; Matsumoto N; Kitagawa T; Inouye K
    J Immunol Methods; 1990 Dec; 134(2):227-35. PubMed ID: 2254668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of antibodies to platelet activating factor.
    Smal MA; Baldo BA; Redmond JW
    Mol Immunol; 1989 Aug; 26(8):711-9. PubMed ID: 2811869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.